comparemela.com

Shore Capital restated their house stock rating on shares of Destiny Pharma (LON:DEST – Get Rating) in a research report sent to investors on Saturday, Marketbeat Ratings reports. Destiny Pharma Stock Performance DEST opened at GBX 31 ($0.38) on Friday. Destiny Pharma has a 1-year low of GBX 29.20 ($0.36) and a 1-year high of […]

Related Keywords

United Kingdom ,Nick Rodgers ,Destiny Pharma Company Profile ,Shore Capital ,Destiny Pharma ,Get Rating ,Marketbeat Ratings ,Destiny Pharma Daily ,Lon Dest ,Odest ,Medical ,Reiterated Rating ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.